Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
Go back to Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System| VERACYTE (NASDAQ: VCYT) | Delayed: 38.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.50 | 52 Week High | $8.45 | |||
| Open | $38.50 | 52 Week Low | $4.21 | |||
| Day High | $38.50 | P/E | N/A | |||
| Day Low | $38.50 | EPS | $-1.52 | |||
| Volume | 205 | |||||
